Clinical trials: HIV-2 Infection
HIV Infections
Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients
The purpose of this study is to evaluate the efficacy of raltegravir with optimized background therapy (OBT) in multiple-experienced HIV infected patients, measured by the proportion of patients with undetectable viral load and…
- Trial name
- NCT01190124
- Volunteers
- 151 people
- Sponsor
- Doroana, Maria Manuela, M.D.
HIV-2 Infection
Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
The HIV-2 is less common ie 1-2 million people in West Africa. HIV-2 does have the same sensitivity to antiretroviral treatment (ART) compared to HIV-1.
- Trial name
- VIH-2 (NCT01605890)
- Testing
- emtricitabine / tenofovir disoproxil fumarate / raltegravir .
- Where
- France
- Volunteers
- 30 people
- Sponsor
- ANRS, Emerging Infectious Diseases
HIV-2 Infection
An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal
There is a critical need for safe and effective antiretroviral treatment (ART) regimens for HIV-2 infection. This is especially true in West Africa, where the vast majority of the 1-2 million individuals infected with HIV-2 live…
- Trial name
- Stribild HIV-2 (NCT02180438)
- Testing
- Stribild (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF) 1 tablet daily X 48 weeks
- Where
- Senegal
- Volunteers
- 30 people
- Sponsor
- University of Washington